A New Frontier in Alzheimer’s Research: King’s College London Identifies Potential Disease-Modifying Drug
Comments Off on A New Frontier in Alzheimer’s Research: King’s College London Identifies Potential Disease-Modifying Drug
July 17, 2026
In the relentless global pursuit of a viable treatment for Alzheimer’s disease, researchers at King’s College London (KCL) have unveiled a breakthrough that could fundamentally shift the therapeutic landscape. A new study published by the team highlights…
